B. Braun recalls lot of lactated Ringer's injection over particulate contamination

B. Braun has voluntarily recalled a single lot of Excel Lactated Ringer’s Injection, 1000 mL, after the company identified particulate matter in the solution.¹ The contaminants were identified as cellulose cotton fibers, with individual particles also identified as cellulose wood fiber and polystyrene, according to the recall notice posted to the FDA's website on August 19, 2026.¹

The FDA's Center for Veterinary Medicine is circulating the alert to veterinary audiences even though the product carries a human-use label. A balanced electrolyte fluid used to correct dehydration and fluid imbalances, lactated Ringer’s solution is a routine part of veterinary fluid therapy across species, administered intravenously or subcutaneously in general practice, emergency, and surgical settings. Facilities that draw fluids from human-labeled inventory, as many veterinary practices and hospitals do, may have received the affected lot.

What's affected

The recalled product is Excel Lactated Ringer’s Injection, 1000 mL, catalog number L7500, NDC 0264-7750-00, lot J4H077, with an expiration date of November 30, 2026.¹

B. Braun distributed the lot nationwide in the United States and to Canada, to hospitals and health care facilities, between August 29, 2024, and September 30, 2024.¹

Why it matters clinically

Particulate matter administered intravenously carries a mechanical risk independent of the fluid itself. The FDA's notice states that the defect creates “a reasonable probability” of pulmonary emboli, occlusion of other blood vessels that can lead to tissue death and organ damage, and phlebitis, as well as the potential for systemic immune activation, organ dysfunction, and hemolysis. B. Braun has not received any reports of adverse events tied to this lot as of the recall date.¹

What to do

Practices and hospitals should check on-hand intravenous fluid stock against lot J4H077 (catalog L7500, NDC 0264-7750-00) and quarantine any matching units.

B. Braun says it is notifying affected accounts by mail with instructions for return and replacement. Facilities can also reach the company directly at recalls@bbraunusa.com from Monday through Friday, 8 AM to 5 PM EST, with questions about the recall.¹

Adverse events or quality problems associated with the product can be reported to FDA MedWatch at 1-800-332-1088 or www.fda.gov/medwatch/report.htm.

References

1. B. Braun Medical Inc issues voluntary North American recall of Excel Lactated Ringer’s Injection, 1000mL due to the presence of particulate matter. News release. FDA. August 19, 2026. Accessed August 24, 2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/b-braun-medical-inc-issues-voluntary-north-american-recall-excelr-lactated-ringers-injection-1000ml